SYNGAP: Bridging the gap between genetic factors and autosomal non-syndromic mental retardation

Clinical Genetics

Volumn 76, Issue 2, 2009, Pages 149-151

  Huang, K ^a  

^a Centre for Molecular Medicine and Therapeutics   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; PROTEIN SYNGAP1; UNCLASSIFIED DRUG;

AUTISM; AUTOSOMAL NON SYNDROMIC MENTAL RETARDATION; AUTOSOMAL RECESSIVE INHERITANCE; CODON; COGNITION; DENDRITIC SPINE; EPILEPSY; GENE IDENTIFICATION; GENE MUTATION; HETEROZYGOSITY; HUMAN; LEARNING; MENTAL DEFICIENCY; NERVE CELL PLASTICITY; NOTE; PRIORITY JOURNAL; PROTEIN DOMAIN; X CHROMOSOME LINKED DISORDER;

EID: 70349983076     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2009.01247_3.x     Document Type: Note

References (13)

1. Leonard H, Wen X. The epidemiology of mental retardation: challenges and opportunities in the new millennium. Ment Retard Dev Disabil Res Rev 2002, 8(3):117-134.
2. Chelly J, Khelfaoui M, Francis F, Cherif B, Bienvenu T. Genetics and pathophysiology of mental retardation. Eur J Hum Genet 2006, 14(6):701-713.
3. Humeau Y, Gambino F, Chelly J, Vitale N. X-linked mental retardation: focus on synaptic function and plasticity. J Neurochem 2009, 109(1):1-14.
4. Molinari F, Rio M, Meskenaite V. Truncating neurotrypsin mutation in autosomal recessive nonsyndromic mental retardation. Science 2002, 298(5599):1779-1781.
5. Motazacker MM, Rost BR, Hucho T. A defect in the ionotropic glutamate receptor 6 gene (GRIK2) is associated with autosomal recessive mental retardation. Am J Hum Genet 2007, 81(4):792-798.
6. Higgins JJ, Pucilowska J, Lombardi RQ, Rooney JP. A mutation in a novel ATP-dependent Lon protease gene in a kindred with mild mental retardation. Neurology 2004, 63(10):1927-1931.
7. Basel-Vanagaite L, Attia R, Yahav M. The CC2D1A, a member of a new gene family with C2 domains, is involved in autosomal recessive non-syndromic mental retardation. J Med Genet 2006, 43(3):203-210.
8. Kerchner GA, Nicoll RA. Silent synapses and the emergence of a postsynaptic mechanism for LTP. Nat Rev Neurosci 2008, 9(11):813-825.
9. Laumonnier F, Cuthbert PC, Grant SG. The role of neuronal complexes in human X-linked brain diseases. Am J Hum Genet 2007, 80(2):205-220.
10. Rumbaugh G, Adams JP, Kim JH, Huganir RL. SynGAP regulates synaptic strength and mitogen-activated protein kinases in cultured neurons. Proc Natl Acad Sci U S A 2006, 103(12):4344-4351.
11. Li W, Okano A, Tian QB. Characterization of a novel synGAP isoform, synGAP-beta. J Biol Chem 2001, 276(24):21417-21424.
12. Kim JH, Liao D, Lau LF, Huganir RL. SynGAP: a synaptic RasGAP that associates with the PSD-95/SAP90 protein family. Neuron 1998, 20(4):683-691.
13. Krapivinsky G, Medina I, Krapivinsky L, Gapon S, Clapham DE. SynGAP-MUPP1-CaMKII synaptic complexes regulate p38 MAP kinase activity and NMDA receptor-dependent synaptic AMPA receptor potentiation. Neuron 2004, 43(4):563-574.